Abacus FCF Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
365,410
+73,911
| +25% | +$3.42M | 2.37% | 15 |
|
|
2025
Q1 | $17.8M | Buy |
291,499
+88,141
| +43% | +$5.38M | 2.79% | 7 |
|
|
2024
Q4 | $11.5M | Buy |
203,358
+81,017
| +66% | +$4.58M | 1.51% | 13 |
|
|
2024
Q3 | $6.33M | Buy |
122,341
+9,496
| +8% | +$491K | 1.47% | 13 |
|
|
2024
Q2 | $4.69M | Buy |
112,845
+2,440
| +2% | +$101K | 1.16% | 16 |
|
|
2024
Q1 | $5.99M | Buy |
110,405
+8,095
| +8% | +$439K | 1.5% | 15 |
|
|
2023
Q4 | $5.25M | Buy |
102,310
+67,856
| +197% | +$3.48M | 1.52% | 11 |
|
|
2023
Q3 | $2M | Sell |
34,454
-536
| -2% | -$31.1K | 1.06% | 19 |
|
|
2023
Q2 | $2.24M | Buy |
34,990
+5,076
| +17% | +$325K | 1.13% | 17 |
|
|
2023
Q1 | $2.07M | Buy |
29,914
+7,986
| +36% | +$554K | 1.11% | 17 |
|
|
2022
Q4 | $1.58M | Sell |
21,928
-492
| -2% | -$35.4K | 1.03% | 23 |
|
|
2022
Q3 | $1.59M | Sell |
22,420
-4,075
| -15% | -$290K | 1.1% | 11 |
|
|
2022
Q2 | $2.04M | Sell |
26,495
-30,564
| -54% | -$2.35M | 1.25% | 15 |
|
|
2022
Q1 | $4.17M | Buy |
57,059
+32,786
| +135% | +$2.39M | 1.39% | 9 |
|
|
2021
Q4 | $1.51M | Hold |
24,273
| – | – | 0.74% | 52 |
|
|
2021
Q3 | $1.46M | Hold |
24,273
| – | – | 0.71% | 53 |
|
|
2021
Q2 | $1.62M | Buy |
+24,273
| New | +$1.62M | 0.83% | 38 |
|